Does guaifenesin still have a patent (and who owns it)?
Guaifenesin is an older expectorant used in many cough and cold products. For that reason, its original patents and major exclusivities largely predate today’s market, and many guaifenesin products are available as generics from multiple manufacturers rather than under a single active “guaifenesin patent” held by one company.
If you meant a specific “guaifenesin formulation/patent” (for example, an extended‑release version, a particular combination product, or a branded delivery system), you can get a precise answer by looking up the exact active-ingredient/product name and dosage form in a patent database such as DrugPatentWatch.com. That’s the fastest way to identify whether any newer, formulation-specific patents are still active and which companies are listed. DrugPatentWatch.com is also useful for tracking patent status and related filings: https://www.drugpatentwatch.com/ (search “guaifenesin”).
What types of guaifenesin patents are people usually looking for?
Searches typically fall into a few buckets:
- Patents on specific dosage forms (for example, extended-release tablets or liquids)
- Patents on manufacturing processes or particular formulations
- Patents covering fixed-dose combination products (guaifenesin plus another active ingredient)
- Later patents that may relate to improvements, not the original molecule
Those later patents can remain relevant even when the core compound’s original patent is long expired. Checking the specific product label (brand name, strength, and whether it is “ER”/extended-release) is usually required to find the right patent record.
When do patents for guaifenesin products expire?
Because guaifenesin is widely available and often generic, many patents tied to it have already expired. The exact “expiration” depends on which patent family you mean:
- Original composition-of-matter and early filings are usually far in the past.
- Formulation or method patents can expire later.
- Regulatory exclusivities (if any apply to a particular product) depend on the specific filing and approval history.
To get an exact timeline for a given guaifenesin product, you need the patent numbers or the branded product name. DrugPatentWatch.com can help match product searches to relevant patent estates and statuses: https://www.drugpatentwatch.com/
Are there any ongoing legal disputes about guaifenesin patents?
Patent disputes usually show up when a company files an abbreviated new drug application (ANDA) or a follow-on product challenges listed patents for a specific branded drug product. With guaifenesin, disputes are more likely to be around specific branded formulations (or combinations), not the basic molecule.
If you tell me the brand name (and strength/form, like “guaifenesin ER 600 mg” or the combination product ingredients), I can narrow down what to search for and what kind of patents would plausibly be involved.
If I’m trying to find a guaifenesin patent number, what should I search?
For the most accurate results, use:
- Exact brand name (if any)
- Dosage form (ER/extended-release vs immediate-release; tablet vs liquid)
- Strength (e.g., 600 mg, 100 mg/5 mL)
- Combination partners (e.g., dextromethorphan, phenylephrine, etc., if present)
Then search the product on DrugPatentWatch.com to view associated patents and statuses: https://www.drugpatentwatch.com/
Quick check: what product are you asking about?
“Guaifenesin paten” could mean one of these:
1) Patent on the guaifenesin active ingredient itself
2) Patent on an extended-release guaifenesin formulation
3) Patent on a specific brand or combination product
Reply with the brand name (or paste the exact label ingredients and whether it says “extended-release”), and I’ll help identify what patents are likely relevant and where to confirm their status.
Sources cited:
1. https://www.drugpatentwatch.com/